These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8030304)

  • 1. [The characteristics of using visken in middle-aged and elderly patients with arterial hypertension].
    Tokar AV; Iena LM; Kozymenko TM; Shyshkina OS
    Lik Sprava; 1993; (10-12):34-8. PubMed ID: 8030304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of visken and hypothiazide on the indices of the central and renal hemodynamics in patients with atherosclerotic hypertension].
    Shishkina OS
    Vrach Delo; 1990 Apr; (4):41-3. PubMed ID: 2275163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension].
    Savenkov PM; Doshitsin VL; Grudtsyn GV
    Kardiologiia; 1977 Oct; 17(10):62-6. PubMed ID: 599799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of Visken-15 for treating hypertension].
    Erina EV; Megrelishvili RI; Pushkar' IuT; Beliakova EV; Lediashova GA
    Kardiologiia; 1979 Mar; 19(3):46-52. PubMed ID: 372668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].
    Werning C; Vetter H
    Adv Clin Pharmacol; 1976; 11():54-60. PubMed ID: 1032571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Change in the central and regional (brain) hemodynamics in the treatment of hypertension using beta-adrenergic blockaders].
    Erina EV; Basishvili NZ; Elizarova NA; Kheĭmets GI
    Kardiologiia; 1976 Jul; 16(7):82-7. PubMed ID: 10464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Capillary blood circulation in middle-aged and elderly arterial hypertension patients].
    Tokar' AV; Kucher VL
    Kardiologiia; 1978 Dec; 18(12):20-3. PubMed ID: 732077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of visken and hyperstat in hypertensive crisis].
    Gorbacgenkov AA; Savenkov PM; Klevtsova MN; Ozherel'eva NI; Albegov AS
    Kardiologiia; 1979 Aug; 19(8):95-9. PubMed ID: 491366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct 24-hour haemodynamic monitoring after starting beta-blocker therapy: studies with pindolol in hypertension.
    v d Meiracker A; Man in't Veld AJ; van Eck HR; Wenting GJ; Schalekamp MA
    J Hypertens Suppl; 1984 Dec; 2(3):S581-3. PubMed ID: 6100755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study on the effects of pindolol and propranolol on systemic and cardiac haemodynamics in hypertensive patients.
    Velasco M; Morillo J; Ramirez A; Hernández E; Vizcarrondo H; Urbin-Aquintana A; López JM; Medrano G; Hernández-Pieretti O
    Int J Clin Pharmacol Res; 1983; 3(2):95-100. PubMed ID: 6384072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of treatment with pindolol (Visken) on hemodynamics in patients with primary hypertension].
    Wyrzykowski B; Suchecka-Rachoń K
    Kardiol Pol; 1986; 29(4):285-91. PubMed ID: 3537436
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of beta-adrenergic blockaders in the treatment of arterial hypertension].
    Erina EV; Basishvili NZ
    Kardiologiia; 1978 Mar; 18(3):28-35. PubMed ID: 25351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of visken in hypertension associated with ischemic heart disease and nutritional obesity].
    Khomenko VL; Vasiuk IuA; Romashkin AV; Sivkov SI; Mel'nikov AIu; Buskin VD
    Sov Med; 1990; (3):64-7. PubMed ID: 2195673
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of the treatment with propranolol and pindolol on selected hemodynamic parameters in patients with primary arterial hypertension].
    Trojnar R; Markiewicz M; Rymar B; Wysokiński A
    Wiad Lek; 1989 Aug 15-Sep 15; 42(16-18):929-34. PubMed ID: 2701039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical use of pindolol (Visken) in the treatment of arterial hypertension].
    Lambić IS; Krstić Lj
    Srp Arh Celok Lek; 1977 Feb; 105(2):191-200. PubMed ID: 905885
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of beta-blockader visken in children with primary arterial hypertension].
    Nadezhdina EA; Vul'fson IN; Ivanitskaia IN; Kurbatov VS; Kupriianova OO
    Kardiologiia; 1976 May; 16(5):71-5. PubMed ID: 7701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the beta-receptor blocking agent visken on blood pressure of hypertensive patients, on plasma renin activity and electrolytes.
    Sonkodi S; Pap A; Varró V
    Ther Hung; 1976; 24(2):60-2. PubMed ID: 982340
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-arrhythmic and hemodynamic effects of visken and glucagon in rhythm disorders in the acute phase of myocardial infarct].
    Golikov AP; Orlov AI; Ivleva VI; Stepura OB
    Kardiologiia; 1980 Oct; 20(10):35-40. PubMed ID: 6108378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
    Persson I
    Adv Clin Pharmacol; 1976; 11():1114-8. PubMed ID: 802071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Visken in the treatment of arterial hypertension].
    Sznajderman M; Brym E
    Pol Tyg Lek; 1975 Dec; 30(50):2105-7. PubMed ID: 1197105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.